Chemotherapy-evoked Painful Peripheral Neuropathy
Open Access
- 1 March 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 2 (1), 8-14
- https://doi.org/10.1046/j.1526-4637.2001.002001008.x
Abstract
Vincristine and paclitaxel, two of the most effective drugs in the battle against cancer, produce a dose-limiting neurotoxicity that sometimes presents as a painful peripheral neuropathy. For the first time, investigators have been able to produce these chemotherapy-evoked painful peripheral neuropathies in the laboratory rat. These new models have already begun to elucidate the causes of the neuropathic pain associated with these antineoplastic drugs, which will now make it possible to search for effective ways to prevent and treat it.Keywords
This publication has 41 references indexed in Scilit:
- DiscussionBiochemical Pharmacology, 1999
- Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testingJournal of Neuro-Oncology, 1997
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studiesAnnals of Neurology, 1994
- Taxol causes permanent large fiber peripheral nerve dysfunction: a lesson for preventative strategiesJournal of Neuro-Oncology, 1993
- Neurotoxicity of antineoplastic agentsCritical Reviews in Oncology/Hematology, 1993
- Effects of taxol on slow and fast axonal transportCell Motility, 1988
- Vincristine NeurotoxicityMedical Toxicology, 1986
- Taxol: an antimitotic agent with a new mechanism of actionPharmacology & Therapeutics, 1984
- Taxol binds to polymerized tubulin in vitroThe Journal of cell biology, 1981